The Basics of Pain Management for Cancer Patients from Diagnosis to Palliative Care: A Comprehensive Overview
(4)
Course | English | 2024 | 2 Hrs
Image For Activity Cover
Availability
On-Demand
Cost
$0.00
Credit Offered
2 ACCME Credits
2 Certificate of Attendance Credits
2 CNE Credits
This course offers a thorough exploration of pain management for cancer patients, addressing various aspects from diagnosis to palliative care. It combines essential pharmacological knowledge, guidance from National Comprehensive Cancer Network (NCCN) guidelines, comprehensive patient assessment skills, and a review of alternative pain management options to equip healthcare professionals with a holistic understanding of cancer pain management. 

Sponsored by The International Association for the Study of Lung Cancer and Evolve Medical Education.

                                                 
Enduring Activity Launch Date: February 29, 2024
Enduring Activity Expiration Date: March 1, 2025
This certified CE/CME activity is designed for specialty physicians, nurses, physician assistants, and nurse practitioners who treat cancer patients.
Upon completion of this activity, the participants should be able to:
  • Illustrate how to effectively assess and screen cancer patients that require pain management.
  • Outline pharmacological options and alternate therapies for treating cancer pain.
  • Discuss the National Comprehensive Cancer Network (NCCN) cancer pain management guidelines.
  • Determine when to re-evaluate the need for long-term pain management.
This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies.
Chair:
  • Pranshu Mohindra, MD, Vice-Chair of Operations and Quality, Department of Radiation Oncology, UH Cleveland Medical Center, Director, UH Proton Therapy Center, UH Seidman Cancer Center Faculty, Case Western Reserve University School of Medicine, Cleveland, OH, USA 
Faculty:
  • Shahed N. Badiyan, MD, Associate Professor, Department of Radiation Oncology, UT Southwestern Medical Center, Dallas, TX, USA 
  • Toby Campbell, MD, MSCI, FAAHPM, Professor of Medicine on Oncology, Thoracic Oncologist, Chief of Palliative Care and the Ellen and Peter O. Johnson Chair in Palliative Care, The University of Wisconsin, Madison, WI, USA 
  • Lauren Chiec, MD, Thoracic Medical Oncologist, University Hospitals Seidman Cancer Center, Cleveland, OH, USA 
  • Chih-Peng Lin, MD, MS, PhD, FIPP, CIPS, Attending Pain Physician and Anesthesiologist, Department of Anesthesiology, National Taiwan University Hospital, Taipei City, Taiwan 
  • Tiffany Michalowski, PharmD, BCGP, Clinical Pharmacy Specialist, Palliative Care, The Johns Hopkins Hospital, Baltimore, MD, USA 
  • Jaclyn Yoong, MBBS (Hons), FRACP, FAChPM, MPH, Associate Professor, Medical Oncologist, Palliative Care Physician Northern Health, Monash Health, Monash University, Melbourne, Australia 
  • Jeanie Youngwerth, MD, FAAHPM, Associate Professor of Medicine, Palliative Care Physician, University of Colorado Anschutz Medical Campus, Denver, CO, USA 
The following planners, speakers, reviewers, or staff have relevant financial relationships to disclose: 

Full Legal Name Commercial Interest Role Level of Participation in the Activity
Shahed Badiyan Merck, Elekta Consultant Speaker
Toby Campbell Novocure, Genentech Advisor Speaker
Jaclyn Yoong 1. AstraZeneca, MSD, Roche
2. AstraZeneca, Roche
1. Speakers Bureau
2. Advisory Board
Speaker


"I have at present or have had within the last 24 months, a financial relationship with one or more ineligible companies."

These relationships with ineligible companies have been mitigated by the International Association for the Stufy of Lung Cancer (IASLC). 

All other presenters, planners, editors, or staff report no relationshops to disclose:

"I do not have at present nor have had within the last 24 months, any financial relationships with ineligible companies."

Accreditation Statement:
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The International Association for the Study of Lung Cancer (IASLC) and Evolve Medical Education (Evolve). IASLC is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statements:

Physicians

The International Association for the Study of Lung Cancer designates the enduring format for this educational activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Registered Nurses
Evolve is approved by the California Board of Registered Nursing, Provider Number 17004, for 2.0 contact hours.

Physician Assistants
PAs may claim a maximum of 2.0 Category 1 credit for completing this activity. The National Commission on Certification of Physician Assistants (NCCPA) accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.

Nurse Practitioners
The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Individuals are responsible for checking with the AANPCP for further guidelines.

The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of IASLC, Evolve, or the Opioid Analgesic REMS Program Companies. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; participants should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:
  1. Read about the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or print it out, if applicable.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test.
  4. Complete the activity evaluation to provide feedback for future programming and receive credit.
You may now view or print the certificate from your CME/CE Transcript. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Transcript and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Transcript.

*The credit that you receive is based on your membership profile.
If you need assistance with this activity, please email: education@iaslc.org.
Powered By